{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:26:13Z","timestamp":1793039173671,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009432","name":"Government Council on Grants, Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.autrev.2020.102695","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:44:42Z","timestamp":1603889082000},"page":"102695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["SARS-CoV-2, the autoimmune virus"],"prefix":"10.1016","volume":"19","author":[{"given":"Gilad","family":"Halpert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.autrev.2020.102695_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2020-217618","article-title":"Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?","volume":"79","author":"Ruscitti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102695_bb0010","first-page":"1130","article-title":"Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome an immunomodulatory perspective to alleviate the storm front","volume":"11","author":"Ruscitti","year":"2020","journal-title":"Immunol."},{"issue":"6","key":"10.1016\/j.autrev.2020.102695_bb0015","doi-asserted-by":"crossref","first-page":"102538","DOI":"10.1016\/j.autrev.2020.102538","article-title":"Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning","volume":"19","author":"Shoenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2020.102695_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity."},{"issue":"10229","key":"10.1016\/j.autrev.2020.102695_bb0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"issue":"8","key":"10.1016\/j.autrev.2020.102695_bb0030","first-page":"517","article-title":"Hyperstimulation of adaptive immunity as the common pathway for silicone breast implants, autoimmunity, and lymphoma of the breast","volume":"21","author":"Watad","year":"2019","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2020.102695_bb0035","first-page":"249","article-title":"Hyperferritinemia in critically ill COVID-19 patients - is ferritin the product of inflammation or a pathogenic mediator? Clinica chimica acta; international journal of clinical chemistry","volume":"509","author":"Gomez-Pastora","year":"2020","journal-title":"Oct"},{"key":"10.1016\/j.autrev.2020.102695_bb0040","series-title":"Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation? Artificial organs","author":"Vlahakos","year":"2020"},{"key":"10.1016\/j.autrev.2020.102695_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2020.102695_bb0050","article-title":"Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection","volume":"28","author":"Lalueza","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"22","key":"10.1016\/j.autrev.2020.102695_bb0055","first-page":"429","article-title":"Ferritin as a marker of severity in COVID-19 patients: a fatal correlation","volume":"8","author":"Dahan","year":"2020","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"10.1016\/j.autrev.2020.102695_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s15010-014-0683-4","article-title":"Ferritin levels predict severe dengue","volume":"43","author":"Soundravally","year":"2015","journal-title":"Infection."},{"issue":"11","key":"10.1016\/j.autrev.2020.102695_bb0065","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s10067-020-05359-y","article-title":"High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: high levels of anti-SSA\/Ro antibodies in COVID-19","volume":"39","author":"Fujii","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102695_bb0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Zhang","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.autrev.2020.102695_bb0075","article-title":"Auto-antibodies against type I IFNs in patients with life-threatening COVID-19","volume":"24","author":"Bastard","year":"2020","journal-title":"Science."},{"issue":"7089","key":"10.1016\/j.autrev.2020.102695_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.autrev.2020.102695_bb0085","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2020.102695_bb0090","doi-asserted-by":"crossref","first-page":"102666","DOI":"10.1016\/j.autrev.2020.102666","article-title":"What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?","volume":"14","author":"De Lorenzis","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2020.102695_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12026-016-8817-7","article-title":"HLA-DRB1 the notorious gene in the mosaic of autoimmunity","volume":"65","author":"Arango","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102695_bb0100","article-title":"HLA genetic polymorphisms and prognosis of patients with COVID-19","volume":"6","author":"Lorente","year":"2020","journal-title":"Med Intensiva"},{"key":"10.1016\/j.autrev.2020.102695_bb0105","article-title":"Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis","volume":"13","author":"Tomita","year":"2020","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.autrev.2020.102695_bb0110","article-title":"HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients","volume":"22","author":"Novelli","year":"2020","journal-title":"Hla."},{"issue":"1","key":"10.1016\/j.autrev.2020.102695_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02686087","article-title":"Molecular mimicry and auto-immunity","volume":"32","author":"Blank","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2020.102695_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000502889","article-title":"Human papillomavirus epitope mimicry and autoimmunity: the molecular truth of peptide sharing","volume":"86","author":"Kanduc","year":"2019","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102695_bb0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.autrev.2020.102695_bb0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2020.102695_bb0135","article-title":"Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report","volume":"18","author":"Baghbanian","year":"2020","journal-title":"Acta Neurol Belg"},{"issue":"6","key":"10.1016\/j.autrev.2020.102695_bb0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0b013e3282f0ad25","article-title":"Viral infection can induce the production of autoantibodies","volume":"19","author":"Barzilai","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102695_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1422.059","article-title":"Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report","volume":"1108","author":"Barzilai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.autrev.2020.102695_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102695_bb0155","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/0961203310365715","article-title":"Clinical and molecular evidence for association of SLE with parvovirus B19","volume":"19","author":"Pavlovic","year":"2010","journal-title":"Lupus."},{"issue":"4","key":"10.1016\/j.autrev.2020.102695_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaut.2008.08.004","article-title":"The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity","volume":"31","author":"Shoenfeld","year":"2008","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2020.102695_bb0165","first-page":"308","article-title":"The environment and autoimmune diseases","volume":"154","author":"Watad","year":"2015","journal-title":"Harefuah."},{"issue":"8","key":"10.1016\/j.autrev.2020.102695_bb0170","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102695_bb0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","volume":"76","author":"Sedaghat","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"26","key":"10.1016\/j.autrev.2020.102695_bb0180","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102695_bb0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s13365-020-00858-9","article-title":"Miller fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2","volume":"26","author":"Manganotti","year":"2020","journal-title":"J Neurovirol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102695_bb0190","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1419","article-title":"Immune Thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2","volume":"146","author":"Tsao","year":"2020","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.autrev.2020.102695_bb0195","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic Purpura in a patient with Covid-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.autrev.2020.102695_bb0200","first-page":"9695","article-title":"The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection","volume":"24","author":"Bonometti","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2020.102695_bb0205","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","article-title":"COVID-19 and Kawasaki disease: novel virus and novel case","volume":"10","author":"Jones","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"10239","key":"10.1016\/j.autrev.2020.102695_bb0210","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet."},{"issue":"2\u20133","key":"10.1016\/j.autrev.2020.102695_bb0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12026-014-8573-5","article-title":"Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis","volume":"60","author":"Amital","year":"2014","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.autrev.2020.102695_bb0220","first-page":"1037","article-title":"Olfactory dysfunction and autoimmunity: pathogenesis and new insights","volume":"35","author":"Shamriz","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102695_bb0225","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24491","article-title":"The sense of smell in systemic lupus erythematosus","volume":"60","author":"Shoenfeld","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"22","key":"10.1016\/j.autrev.2020.102695_bb0230","first-page":"335","article-title":"The smell in COVID-19 infection: diagnostic opportunities","volume":"7","author":"David","year":"2020","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"10.1016\/j.autrev.2020.102695_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722030272X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722030272X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:42Z","timestamp":1761599982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722030272X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S156899722030272X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102695","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2, the autoimmune virus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102695"}}